BlackRock Throgmorton Trust plc (THRG)

Category UK Small-Cap Equity

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.

Sell

614.00p

Buy

616.00p

arrow-up0.00p (+0.00%)

Discount/Premium

-7.35%

Estimated NAV

663.804p

Prices updated at 19 Dec 2025, 17:00 GMT

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The objective is to provide shareholders with long term capital growth and an attractive total return through investment primarily in UK smaller and mid-cap companies traded on the LSE. Company may hold up to 15% of its GA, in securities of companies which are listed or traded on a stock exchange outside the UK. In normal circumstances, company will likely hold a mixture of long and short CFDs and/or comparable equity derivatives that would result in a typical net market exposure of between 100% and 115%.In extremis, the Company could deploy the full 30% of permissible leverage into short CFDs and/or comparable equity derivatives, thereby reducing its overall net market exposure to 70%.

FTSE All-Share

0.53%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Director dealings

Date chevron-l-regular chevron-r-regular	Action
12 Sep 2025	D
12 Sep 2025	D
05 Sep 2025	Purchase
25 Apr 2025	Purchase
25 Apr 2025	Sale
25 Apr 2025	Sale
25 Apr 2025	Purchase
15 Apr 2025	D
15 Apr 2025	D
14 Apr 2025	D
27 Feb 2025	Purchase

Director holdings

Name chevron-l-regular chevron-r-regular	Title	Amount (No. of shares)
Mrs. Louise Catherine Nash	Non-Executive Director, Senior Independent Director	5,500
Mr. James Robert Will	Non-Executive Director, Chairman	10,000
Dr. Nigel John Burton	Non-Executive Director	17,583
Ms. Angela Claire Lane	Non-Executive Director	25,143
Ms. Merryn Somerset Webb	Non-Executive Director	3,954

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.